Nutcracker Therapeutics Funding: $167M Raised, Series C
Nutcracker Therapeutics is based in Fremont, CA. It has raised $167M in total funding. Latest round: Series C. Backed by ARCH Venture Partners.
Nutcracker Therapeutics funding overview
Nutcracker Therapeutics is based in Fremont, CA. Nutcracker Therapeutics has raised $167M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in March 2022. The round record for Nutcracker Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include ARCH Venture Partners.
Nutcracker Therapeutics at a glance
Total raised
$167M
Latest round
Series C
Latest round date
March 2022
Headquarters
Fremont, CA
Notable investors
ARCH Venture Partners
Frequently asked about Nutcracker Therapeutics funding
How much has Nutcracker Therapeutics raised?
Nutcracker Therapeutics has raised $167M in total disclosed funding across the rounds on record.
Who has invested in Nutcracker Therapeutics?
ARCH Venture Partners are named among the investors backing Nutcracker Therapeutics.
What was the latest Nutcracker Therapeutics funding round?
The most recent disclosed round is a Series C, announced in March 2022.
Where is Nutcracker Therapeutics based?
Nutcracker Therapeutics is based in Fremont, CA.
When did Nutcracker Therapeutics last raise?
The last disclosed Nutcracker Therapeutics round closed in March 2022 at Series C.
We update the Nutcracker Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Fremont and their backers are listed below.
